Xylitol, a common artificial sweetener, is found in many everyday products, from gum to peanut butter. In 2025 alone, ASPCA Poison Control received over 10,000 calls related to xylitol exposures in dogs, cats, and other companion animals.1
In this webinar, Dr. Julia VanDerslice, DVM, DACVECC, shares her recent clinical experience managing xylitol toxicities and discusses the emerging role of hemoperfusion as a treatment option. She reviews the current understanding of xylitol pharmacology in canine patients and where hemoperfusion may fit within treatment protocols.
Key webinar topics include:
-
Overview of hemoperfusion and its clinical applications
-
Current insights into xylitol pharmacology in dogs
-
Case examples highlighting treatment considerations
